selected publications
-
conference proceeding
- Overview of DNA collection and genotyping conducted by add health. Behavior Genetics: an international journal devoted to research in the inheritance of behavior in animals and man. 795-795. 2007
-
journal article
-
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
European Journal of Pharmaceutics and Biopharmaceutics.
220-228.
2015
-
Common Exposure to STL Polyomavirus During Childhood.
Emerging Infectious Diseases.
1559-1561.
2014
-
Dynamics of urinary polyomavirus shedding in healthy adult women.
Journal of Medical Virology.
1459-1463.
2012
-
Dynamics of pregnancy-associated polyomavirus urinary excretion: A prospective longitudinal study.
Journal of Medical Virology.
1312-1322.
2012
-
Rb-86(+) efflux mediated by alpha 4 beta 2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.
Biochemical Pharmacology.
1238-1251.
2010
- Family-based association tests: HTR1B and conduct disorder phenotypes. Alcoholism: Clinical and Experimental Research. 144A-144A. 2008
-
Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated Rb-86(+) efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
Molecular Pharmacology.
1796-1807.
2008
-
Gene targeting demonstrates that alpha 4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [H-3]epibatidine binding sites and components of biphasic Rb-86(+) efflux with high and low sensitivity to stimulation by acetylcholine.
Neuropharmacology.
390-405.
2007
-
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.
Journal of Neurochemistry.
258-268.
2001
-
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
European Journal of Pharmaceutics and Biopharmaceutics.
220-228.
2015